All of Tarsa's existing investors participated in the financing, including Foresite Capital, MVM Life Science Partners, Quaker Partners and Novo A/S.
Tarsa announced that Nicholas A. LaBella, Jr., MS, RPh, has joined the company as Vice President, Global Regulatory Affairs.